T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells

Cardiovascular Research

Volumn 93, Issue 3, 2012, Pages 498-507

  Philippova, Maria ^a   Joshi, Manjunath B ^a   Pfaff, Dennis ^a   Kyriakakis, Emmanouil ^a   Maslova, Kseniya ^a   Erne, Paul ^b   Resink, Thérèse J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Angiogenic behaviour; Endothelial cell; Insulin resistance; Signal transduction; T cadherin

Indexed keywords

CADHERIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; T CADHERIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID RAFT; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

CADHERINS; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE SILENCING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MEMBRANE MICRODOMAINS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84857602562     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs004     Document Type: Article

References (42)

1. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 2009;335:165-189.
2. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904.
3. Muniyappa R, Iantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am 2008;37:685-711, ix-x.
4. Caballero AE. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 2003;11:1278-1289.
5. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007;28:463-491.
6. Liu Y, Petreaca M, Martins-Green M. Cell and molecular mechanisms of insulin-induced angiogenesis. J Cell Mol Med 2009;13:4492-4504.
7. Zdychova J, Komers R. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res 2005;54:1-16.
8. Berg CE, Lavan BE, Rondinone CM. Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem Biophys Res Commun 2002;293:1021-1027.
9. Ueno M, Carvalheira JB, Tambascia RC, Bezerra RM, Amaral ME, Carneiro EM et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia 2005;48:506-518.
10. Tremblay F, Gagnon A, Veilleux A, Sorisky A, Marette A. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology 2005;146:1328-1337.
11. Matsui T, Nagoshi T, Hong EG, Luptak I, Hartil K, Li L et al. Effects of chronic Akt activation on glucose uptake in the heart. Am J Physiol Endocrinol Metab 2006;290:E789-E797.
12. Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P, Resink TJ. A guide and guard: the many faces of T-cadherin. Cell Signal 2009;21:1035-1044.
13. Ivanov D, Philippova M, Antropova J, Gubaeva F, Iljinskaya O, Tararak e et al. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol 2001;115:231-242.
14. Kudrjashova E, Bashtrikov P, Bochkov V, Parfyonova Y, Tkachuk V, Antropova J et al. Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis. Histochem Cell Biol 2002;118:281-290.
15. Ivanov D, Philippova M, Allenspach R, Erne P, Resink T. T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res 2004;64:132-143.
16. Joshi MB, Philippova M, Ivanov D, Allenspach R, Erne P, Resink TJ. T-cadherin protects endothelial cells from oxidative stress-induced apoptosis. FASEB J 2005;19:1737-1739.
17. Kyriakakis E, Philippova M, Joshi MB, Pfaff D, Bochkov V, Afonyushkin T et al. T-cadherin modulates UPR activation and cell survival during endoplasmic reticulum stress in endothelial cells. Cell Signal 2010;22:1308-1316.
18. Philippova M, Banfi A, Ivanov D, Gianni-Barrera R, Allenspach R, Erne P et al. Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 2006;26:2222-2230.
19. Philippova M, Suter Y, Toggweiler S, Schoenenberger AW, Joshi MB, Kyriakakis e et al. T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis. Eur Heart J 2011;32:760-771.
20. Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med 2009;6:27-35.
21. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest 2010;120:4342-4352.
22. Hebbard LW, Garlatti M, Young LJ, Cardiff RD, Oshima RG, Ranscht B. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res 2008;68:1407-1416.
23. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004;101:10308-10313.
24. Kyriakakis E, Cavallari M, Andert J, Philippova M, Koella C, Bochkov V et al. Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis. Eur J Immunol 2010;40:3268-3279.
25. Pfaff D, Philippova M, Buechner SA, Maslova K, Mathys T, Erne P et al. T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo. Br J Dermatol 2010;163:353-363.
26. Philippova M, Ivanov D, Joshi MB, Kyriakakis E, Rupp K, Afonyushkin T et al. Identification of proteins associating with glycosylphosphatidylinositol- anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78/BiP in T-cadherin-dependent cell survival. Mol Cell Biol 2008;28:4004-4017.
27. Ivanov D, Philippova M, Tkachuk V, Erne P, Resink T. Cell adhesion molecule T-cadherin regulates vascular cell adhesion, phenotype and motility. Exp Cell Res 2004;293:207-218.
28. Timmins NE, Nielsen LK. Generation of multicellular tumor spheroids by the hangingdrop method. Methods Mol Med 2007;140:141-151.
29. Joshi MB, Ivanov D, Philippova M, Kyriakakis E, Erne P, Resink TJ. A requirement for thioredoxin in redox-sensitive modulation of T-cadherin expression in endothelial cells. Biochem J 2008;416:271-280.
30. Choi K, Kim YB. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 2010;25:119-129.
31. Zhande R, Mitchell JJ, Wu J, Sun XJ. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol Cell Biol 2002;22:1016-1026.
32. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-1545.
33. Philippova MP, Bochkov VN, Stambolsky DV, Tkachuk VA, Resink TJ. T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett 1998;429:207-210.
34. Joshi MB, Ivanov D, Philippova M, Erne P, Resink TJ. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3{beta} in endothelial cells. FASEB J 2007;21:3083-3095.
35. Saltiel AR, Pessin JE. Insulin signaling in microdomains of the plasma membrane. Traffic 2003;4:711-716.
36. Andersen AS, Kjeldsen T, Wiberg FC, Vissing H, Schaffer L, Rasmussen JS et al. Identification of determinants that confer ligand specificity on the insulin receptor. J Biol Chem 1992;267:13681-13686.
37. Slaaby R, Schaffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, Mathiasen IS et al. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J Biol Chem 2006;281:25869-25874.
38. Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal 2005;7:1021-1031.
39. Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol 2000;55:221-232.
40. Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, Ho HY et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes 2011;60:2417-2423.
41. Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T et al. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in Japanese population. Hum Mutat 2011; doi:10.1002/humu.21652.
42. Tyrberg B, Miles P, Azizian KT, Denzel MS, Nieves ML, Monosov EZ et al. T-cadherin (Cdh13) in association with pancreatic beta-cell granules contributes to second phase insulin secretion. Islets 2011;3:327-337.